老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Anavex Life Sciences Corp.

3.66
+0.01030.28%
成交量：427.53万
成交额：1,556.44万
市值：3.14亿
市盈率：-6.45
高：4.04
开：3.51
低：3.29
收：3.65
52周最高：14.44
52周最低：2.86
股本：8,589.38万
流通股本：8,304.81万
量比：0.85
换手率：5.15%
股息：- -
股息率：- -
每股收益(TTM):-0.5666
每股收益(LYR):-0.5152
净资产收益率：-43.64%
总资产收益率：-27.41%
市净率：3.45
市盈率(LYR):-7.10

数据加载中...

总览公司新闻资讯公告
2022/02/02

重要事件披露

8-K - Current report
2021/09/13

重要事件披露

ANAVEX LIFE SCIENCES CORP.
2021/08/04

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/04

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/04

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/04

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/04

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/06/24

重要事件披露

8-K - Current report
2021/05/28

重要事件披露

8-K - Current report
2021/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/12/28

重要事件披露

8-K - Current report
2020/12/15

重要事件披露

8-K - Current report
2020/11/06

重要事件披露

8-K - Current report
2020/10/15

重要事件披露

8-K - Current report
2020/08/06

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
更多